U.S. markets closed

1Life Healthcare, Inc. (ONEM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
50.31+0.83 (+1.68%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Engulfing Line (Bearish)

Engulfing Line (Bearish)

Previous Close49.48
Open50.31
Bid50.25 x 900
Ask50.70 x 1200
Day's Range48.51 - 50.61
52 Week Range15.00 - 55.12
Volume1,141,290
Avg. Volume1,419,835
Market Cap6.692B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    Leading $2.8 Trillion US Healthcare Market: CEO’s of 1life Healthcare, Skylight Health, Veeva Systems, and Teladoc - Driving Explosive Revenue Growth with Innovation and New Market Expansions

    NEW YORK, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: 1life Healthcare (NASDAQ: ONEM), Skylight Health Group (TSX.V: SHG) (OTC: SHGFF) Teladoc Health (NYSE: TDOC), and Veeva Systems (NYSE: VEEV). The US healthcare market is estimated at $2.8 trillion - and the largest in the world. Fast moving innovators are now driving a transformation wave - and creating new opportunities for investors. Wall Street Reporter highlights the latest comments from industry thought leaders:1life Healthcare (NASDAQ: ONEM) Chairman & CEO, Amir Rubin: “New Market Expansions Provides Long Runway For Growth” “...Our membership count in the quarter surpassed the half a million mark. Q3 membership growth accelerated to 29% year-over-year with momentum across both consumer and enterprise channels, allowing us to reach our year-end membership guidance a quarter early...We also surpassed $100 million in net revenue for the first time in a single quarter, delivering $102 million in total net revenue in Q3, which grew 46% year-over-year. We delivered a care margin of $42.9 million or 42% of net revenue and positive adjusted EBITDA of $3.5 million or 3% of net revenue. These margin results demonstrate the strong leverage components of our model.”“...We are now operating in 12 markets across the United States up 50% over the last 18 months. Throughout 2020, we have expanded into new markets in partnership with both new and existing health network partners. ..by the end of 2021, we plan to have established physical presence in 17 markets, a 40% increase from our 12 markets today, and more than double the markets from where we were 18 months ago. Our partnerships and market expansions provide long runways for growth impact and returns as we increase our reach and value proposition to companies and consumers, while leveraging our technology and operating infrastructure.”1life Healthcare (NASDAQ: ONEM) Earnings Highlights: https://bit.ly/35PBxGESkylight Health Group (TSX.V: SHG) (OTC: SHGFF) CEO, Prad Sekar: “Now At Inflection Point - Positioned for 10X Upside Revenue Growth Potential”Skylight Health Group (TSX.V: SHG) (OTC: SHGFF) was recently a featured presenter at Wall Street Reporter’s NEXT SUPER STOCK livestream investor conference. CEO Prad Sekar, outlined his vision for building Skylight into a multi-billion dollar business focused on the highly fragmented US healthcare market. Skylight already operates 30 clinics, in 14 states, with virtual telehealth overlay, serving over 120,000 patients - and is one of the fastest growing multi-disciplinary health systems in the United States.Watch Skylight (OTC: SHGFF) Next Super Stock livestream video: https://bit.ly/3nqXrpASkylight is now at an inflection point. SHGFF revenues are expected to be $45 million and $5.5 million EBITDA run rates, with a recently announced acquisition. SHGFF boasts a profitable base of operations, no long-term debt and cash balance of $10 million. In his presentation, Skylight CEO Prad Sekar, explains how the company can increase revenues organically by about 10X, as it optimizes clinics for profitability by expansion of services to the existing patient base, with its proven business model. Significantly, Skylight has over $75 million of acquisitions in the pipeline - and growing.January 7 - SHGFF enters into a binding Letter of Intent to purchase 100% of the shares of a US Primary and Urgent Care clinic group with 2020 unaudited revenue of over $20 million and $3 million EBITDA. The acquisition is expected to close Q1 2021.Watch Skylight (OTC: SHGFF) Next Super Stock livestream video: https://bit.ly/3nqXrpAVeeva Systems Inc. (NYSE: VEEV), CEO Peter Gassner: “Veeva’s Cloud Innovation Powering Pharma & LifeSciences”“…Telemedicine increased rapidly in the U.S. from less than 1% of doctor visits in February to more than 30% of visits in April. Doctors and patients are getting used to a mix of in-person and digital interactions and are finding it productive. Using Veeva Pulse data from Veeva CRM, we see that in the U.S., remote meetings between pharma and doctors with Veeva Engage are up more than 30 times and approved e-mail communications are up more than two times from February to April.”“Doctors are telling us they find digital meetings effective and they look forward to a mix of in-person and digital interactions once things get back to normal. It's good to see the healthcare systems and the life sciences industry evolving so rapidly. It was a very busy quarter for Veeva, we executed our first ever entirely remote product releases in both CRM and Vault. We made major changes to our product plans to release new digital capabilities, customers need most right now….Two big new areas of innovation, Data Cloud and MyVeeva: We had a major announcement for commercial in March with Veeva Data Cloud planned for the U.S. by year-end. Veeva Data Cloud will bring a better solution for patient data to the industry. This is a large, underserved area and ripe for disruption. Like the other markets we've entered, we aim to bring much needed innovation…”Veeva Systems (NYSE: VEEV) Earnings Call Highlights Available at: https://bit.ly/2FnuP0wTeladoc Health (NYSE: TDOC) CEO Jason Gorevic: “Virtual Care Trend is Only Accelerating - and Here to Stay (Beyond Pandemic)”“...We reported another quarter of significant outperformance across all key financial and operational metrics driven by broad-based momentum across the entire business. The ongoing pandemic has highlighted the critical role of virtual care within the overall health care system, and we continue to see increasing adoption by consumers, clients and providers...This broad-based strength drove record revenue of $289 million in the third quarter, an increase of 109% from the prior year period, including organic revenue growth of approximately 90%. The strength demonstrated across our diverse channels, products and geographies, combined with a robust pipeline of new opportunities, continues to give us tremendous confidence in the forward outlook for the business.“We continue to see strong evidence of sustained utilization increases for virtual care... One clear driver of this strength has been a steady and broad-based acceleration in our noninfectious disease-related visits. Visits for conditions such as hypertension, back pain, anxiety and depression represent over half of our general medical visit volume, up from approximately 1/3 a year ago, as our comprehensive portfolio of services enables us to meet the increasing consumer demand for virtual care.”“...Momentum in specialty visit growth, combined with the broadening diversity of diagnoses and robust overall registration growth, continues to give us a high degree of confidence in the sustainability of our volume growth. It also reinforces our strategy of consistently expanding the clinical scope of our services, which will take a quantum leap forward when we incorporate the Livongo capabilities focused on helping people who live with chronic conditions.”Teladoc Health (NYSE: TDOC) Earnings Highlights: https://bit.ly/3fg9jItWALL STREET REPORTERWall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO's of promising, publicly-traded companies, and market experts. www.WallStreetReporter.com Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Full disclaimer, and relevant SEC 17B disclosures here: http://bit.ly/39kkE7KAbout Wall Street Reporter’s Next Super Stock conference:Wall Street Reporter's NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/CONTACT:WALL STREET REPORTER(212) 871-2057 ext 7www.WallStreetReporter.com

  • One Medical extends public COVID-19 vaccination efforts to additional communities in partnerships with departments of public health
    GlobeNewswire

    One Medical extends public COVID-19 vaccination efforts to additional communities in partnerships with departments of public health

    High-priority populations will begin receiving vaccinations in New York, Los Angeles, Seattle, and the San Francisco Bay Area, with other regions anticipated soonSAN FRANCISCO, Jan. 12, 2021 (GLOBE NEWSWIRE) -- One Medical, (NASDAQ: ONEM) a leading human-centered and technology-powered primary care organization, today announced it is continuing to expand its COVID-19 vaccination efforts nationwide, now offering support for community vaccinations in New York City, Los Angeles, Seattle, and the greater San Francisco Bay Area, with plans for more geographies soon. With limited quantities of vaccines currently being provided by local departments of public health, One Medical is administering doses to Phase 1a and select Phase 1b populations in accordance with guidance from local, state and federal health officials. One Medical is also providing complimentary telehealth services to qualifying patients referred by departments of public health during the course of vaccination services, leveraging One Medical’s technology platform for vaccine appointment scheduling, second dose vaccine reminders, digital health follow up through video chats and messaging, and data reporting.Beginning this week, One Medical is dedicating a location in Los Angeles to administer vaccines to those referred from the Los Angeles County Department of Public Health. Similar public support efforts are underway in Northern California, where One Medical is working directly with the San Francisco Department of Public Health and other Bay Area county health departments. In New York City and Seattle’s King County, One Medical is also planning to soon administer COVID-19 vaccinations to qualified populations from the general public in accordance with guidance from departments of public health.“With a modernized technology platform, multi-market streamlined operations, and dedicated providers and team members, One Medical is pleased to partner with public health leaders across the nation to serve communities with COVID-19 vaccine administration and digital health support,” said One Medical Chair & CEO, Amir Dan Rubin.About One Medical One Medical is a membership-based and technology-powered primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click. Our vision is to delight millions of members with better health and better care while reducing costs. Our mission is to transform health care for all through our human-centered, technology-powered model.Headquartered in San Francisco, 1Life Healthcare, Inc. is the administrative and managerial services company for the affiliated One Medical physician-owned professional corporations that deliver medical services in-office and virtually. 1Life and the One Medical entities do business under the “One Medical” brand.Media Contact: Kristina Skinner, One Medical Senior Director of External Communications Press@onemedical.com 650-743-5187Investor Contact: Rose Salzwedel, One Medical Director of Investor Relations Investor@onemedical.com 206-331-2211

  • 1Life Healthcare (One Medical) Executives to Participate in Upcoming Investor Conference
    GlobeNewswire

    1Life Healthcare (One Medical) Executives to Participate in Upcoming Investor Conference

    SAN FRANCISCO, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that Amir Dan Rubin, Chair & CEO, and Bjorn Thaler, CFO, will participate in the following upcoming investor conference: * The 39th Annual J.P. Morgan Healthcare Conference which will include a presentation and fireside chat on Tuesday, January 12th at 8:40 a.m. (PT) / 11:40 a.m. (ET). A live audio webcast and a replay of the presentation will be available at https://investor.onemedical.com.About One Medical One Medical is a membership-based and technology-powered primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click. Our vision is to delight millions of members with better health and better care while reducing costs. Our mission is to transform health care for all through our human-centered, technology-powered model.Headquartered in San Francisco, 1Life Healthcare, Inc. is the administrative and managerial services company for the affiliated One Medical physician-owned professional corporations that deliver medical services in-office and virtually. 1Life and the One Medical entities do business under the “One Medical” brand.Investor Contact: Rose Salzwedel, One Medical Director of Investor Relations Investor@onemedical.com 206-331-2211Media Contact: Kristina Skinner, One Medical Senior Director of External Communications Press@onemedical.com 650-743-5187